3D Systems Q2: $94.6M Revenue Hold, Better Profits, and a Real Shot at Turnaround

Q2 held up better than expected because margins improved

This is not a growth stock story yet. After the latest report, though, it looks more like a credible turnaround setup. Revenue was essentially flat, but profitability improved in a way investors can track.

The spread matters more than the raw revenue line

Q2 revenue was $94.6 million, down just 0.3% year over year but up 1.4% excluding divestitures. On the surface, that is not exciting. What matters is what happened underneath it. 3D Systems reported a net loss of $12.9 million, while adjusted EBITDA improved to a loss of $0.8 million. For the first half of 2026, the company generated positive adjusted EBITDA of $1.3 million.

That is the core read: top-line pressure has eased enough for cost control to show up more clearly in the numbers.

Why the next few quarters matter

An EPS beat is fine, but the bigger signal is operating improvement. The watch list is straightforward:

• Keep revenue positive excluding divestitures
• Keep the adjusted EBITDA loss shrinking
• Test whether the first-half positive adjusted EBITDA holds going forward

If those trends continue, the stock has room to re-rate. If they fade, the market will likely treat this quarter as a one-off.

Demand looks real in Healthcare, while Industrial is stabilizing

Cost cuts can clean up a quarter quickly, so investors still need proof that customers are buying because the products solve real problems. On that score, this report looked better than the headline revenue decline suggested.

The product test: new printer sales are helping

Management said Q2 was driven by continued acceleration of new printer sales, including double-digit growth in both metal and polymer hardware printer systems. That matters because equipment demand is a cleaner signal than income-statement management near quarter-end.

Healthcare provides the clearest evidence of underlying demand. The segment grew 6.8% year over year, helped by more than 20% growth in Med Tech and 3% growth in Dental. That suggests customers still see value in 3D Systems' solutions for implants, dental products, and related workflows.

Industrial remains the weak spot, but the damage looks less severe

Industrial revenue still fell 6.7% year over year. That keeps it the weakest part of the business for the full year to date.

Still, the sequential read improved. Industrial revenue rose 2.4% sequentially, including more than 20% growth in Aerospace & Defense. Those details do not prove a recovery, but they make the story look less like unbroken decline and more like a business beginning to stabilize.

The 2026 thesis is still about repair, not explosive growth

The broader backdrop helps explain how investors should frame the quarter. Full-year 2024 revenue was $440 million, and management had already outlined a cost-reduction effort expected to deliver more than $50 million in incremental annualized savings. Earlier guidance pointed to flat to modest organic growth and a path back to positive adjusted EBITDA.

That means this was never really pitched as a flashy growth story at the outset. It was meant to be a simpler one: cut waste, restore basic profitability, and show that customer demand is holding up better than feared.

What needs to happen next for the turnaround case to strengthen

This quarter improved the setup, but it did not close the case. The next few updates need to confirm three things:

• Revenue stays positive ex-divestiture
• Industrial continues to stabilize rather than slip back sharply
• Profitability gains come from operations, not just timing or one-quarter cost benefits

If those checks hold, the thesis shifts from "the cuts worked this quarter" to "customers are genuinely coming back." If not, the turnaround narrative will still be early.